Clinical Trials on Moderate to Severe Glabellar Lines in Denmark
Total 11 results
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
GenVecCompletedModerate to Severe Angina PectorisDenmark, Israel
-
AstraZenecaCompletedModerate to Severe COPDSweden, Bulgaria, Poland, Denmark, Slovakia
-
Mental Health Services in the Capital Region, DenmarkInnovation Fund DenmarkRecruitingModerate Depression | Recurrent Depressive Disorder, Current Episode Moderate | Severe Depressive Episode Without Psychotic Symptoms | Recurrent Depressive Disorder, Current Episode Severe Without Psychotic SymptomsDenmark
-
Galderma R&DRecruitingModerate-to-Severe Atopic DermatitisUnited States, Denmark, Hungary, Poland, Spain
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
Kristian Reich, MDLEO PharmaCompletedMild to Moderate PsoriasisUnited Kingdom, Germany, France, Spain, Netherlands, Sweden, Italy, Denmark
-
SynAct Pharma ApsRecruitingNephrotic Syndrome Due to Idiopathic Membranous Nephropathy | Severe Proteinuria Due to Idiopathic Membranous NephropathyDenmark
-
University of AarhusAarhus University Hospital; Sygehus LillebaeltRecruitingIrritable Bowel Syndrome | Fibromyalgia | Chronic Fatigue Syndrome | Bodily Distress Disorder Moderate | Bodily Distress Disorder Severe | SomatizationDenmark